Neurotechnology firm Synchron has announced the incorporation of OpenAI’s generative artificial intelligence (AI) into its brain-computer interface (BCI) platform, introducing a novel chat feature. This integration aims to enhance the capabilities of Synchron’s BCI technology, enabling individuals with severe paralysis and loss of upper limb mobility to interact with digital interfaces through thought alone.
Oticon Medical has announced that its Sentio System, the company’s first active transcutaneous bone conduction hearing system, has received clearance from the U.S. Food and Drug Administration (FDA). This innovative system aims to provide the established benefits of the company’s Ponto System whilst offering a transcutaneous option.
Royal Philips has announced the successful first implantation of its Duo Venous Stent System following premarket approval from the U.S. Food and Drug Administration. The device is indicated for treating symptomatic venous outflow obstruction in patients with chronic venous insufficiency (CVI).
Royal Philips, a leader in health technology, has launched a new cardiac care platform aimed at transforming diagnostic cardiology in Europe, the Middle East, and Africa. The Philips Cardiac Workstation utilises sophisticated algorithms to expedite the collection and processing of electrocardiograph (ECG) data, potentially streamlining care and helping to prioritise high-risk patients.
GE HealthCare has introduced SIGNA MAGNUS, a novel head-only magnetic resonance imaging (MRI) scanner designed to advance neuroscience research. The device, which is currently pending FDA 510(k) clearance (it is not yet CE marked), aims to overcome the performance limitations of conventional whole-body MR systems that have historically constrained neurological and psychiatric research.
Siemens Healthineers has announced the launch of the Biograph Trinion, a cutting-edge positron emission tomography/computed tomography (PET/CT) scanner that boasts high performance, energy efficiency, and a wide array of clinical capabilities.
Siemens Healthineers has launched new artificial intelligence-enabled cardiology applications and a 4D transoesophageal echocardiography (TEE) transducer for its Acuson Sequoia ultrasound system.
Hologic’s Brevera Breast Biopsy System 7-gauge needle is now available in Europe. This addition expands the suite of Brevera disposable biopsy needles and provides radiologists with more options for their biopsy procedures.
After After Hemovent’s MOBYBOX ECLS system received Medical Device Regulation (MDR 2017/745) certification last year, the MOBYO gas exchanger is following suit and has also successfully received MDR certification. In addition, the MOBYO gas exchanger is now approved for 28-day use.
A novel indwelling catheter called cymactive 2.0R has received CE marking in Europe, allowing it to be marketed for men experiencing chronic, non-neurogenic urinary retention.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
